iSpecimen (ISPC) Expected to Announce Quarterly Earnings on Thursday

iSpecimen (NASDAQ:ISPC) is anticipated to issue its results before the market opens on Thursday, March 12th. Analysts expect the company to announce earnings of ($3.80) per share and revenue of $3.4030 million for the quarter.

iSpecimen Stock Performance

NASDAQ ISPC opened at $0.25 on Wednesday. The firm’s fifty day moving average price is $0.31 and its two-hundred day moving average price is $0.63. The stock has a market cap of $2.44 million, a PE ratio of -0.03 and a beta of 1.87. iSpecimen has a fifty-two week low of $0.22 and a fifty-two week high of $3.18.

Hedge Funds Weigh In On iSpecimen

An institutional investor recently bought a new position in iSpecimen stock. Scientech Research LLC bought a new stake in iSpecimen Inc. (NASDAQ:ISPC) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor bought 29,488 shares of the company’s stock, valued at approximately $38,000. Scientech Research LLC owned about 0.30% of iSpecimen at the end of the most recent reporting period. 13.62% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of iSpecimen in a report on Thursday, January 22nd. One analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company currently has a consensus rating of “Sell”.

About iSpecimen

iSpecimen, Inc (NASDAQ:ISPC) operates an online life sciences marketplace designed to connect researchers with human biological specimens and associated clinical data. The company’s platform streamlines the sourcing of biospecimens—such as plasma, serum, fresh and frozen tissue, saliva, urine and peripheral blood mononuclear cells (PBMCs)—by matching demand from pharmaceutical, biotechnology, diagnostic and academic organizations with supply from a wide network of clinical sites and biobanks.

Through its on-demand procurement model, iSpecimen provides customized specimen collection and fulfillment services that help accelerate research timelines and improve data quality.